世界の非血液がん治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Non-Hematological Cancer Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4163 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、非血液がん治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、手術、放射線療法、その他）、用途別市場規模（病院、腫瘍治療センター、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・非血液がん治療の市場動向 ・企業の競争状況、市場シェア ・非血液がん治療の種類別市場規模（化学療法、手術、放射線療法、その他） ・非血液がん治療の用途別市場規模（病院、腫瘍治療センター、外来手術センター、その他） ・非血液がん治療の北米市場規模2016-2027（アメリカ、カナダ） ・非血液がん治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・非血液がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・非血液がん治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・非血液がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis、Pfizer、Bristol-Myers Squibb、Johnson & Johnson、Roche、Amgen、Astellas Pharma） ・結論

Non-Hematological cancers which cover lung cancer, prostate cancer, breast cancer and others, this type of cancer are not show easily diagnosis and the treatment process is also show long that some time it lead to the death of the patient.
North America has the huge number of population suffering from cancer, according to National Cancer Institute which come under the U.S health, the statistic published in 2016 around 1,685,210 new cancer is diagnosed and 595,690 people died due to cancer. Cancer is the second important cause of death in Europe as per the WHO Regional Office for Europe in 2012, around 3.7 million new cases of cancer occur in Europe and 1.9 million death each year. Same as for Asia Pacific and the creating the awareness is also the necessary aspect to be consider.

Market Analysis and Insights: Global Non-Hematological Cancer Treatment Market
The global Non-Hematological Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Non-Hematological Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Non-Hematological Cancer Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Non-Hematological Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Non-Hematological Cancer Treatment market.

Global Non-Hematological Cancer Treatment Scope and Market Size
Non-Hematological Cancer Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Non-Hematological Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemotherapy
Surgery
Radiation Therapy
Others

Segment by Application
Hospitals
Oncology Treatment Centre
Ambulatory Surgery Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis
Pfizer
Bristol-Myers Squibb
Johnson & Johnson
Roche
Amgen
Astellas Pharma

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Hematological Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Surgery
1.2.4 Radiation Therapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Non-Hematological Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Oncology Treatment Centre
1.3.4 Ambulatory Surgery Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Non-Hematological Cancer Treatment Market Perspective (2016-2027)
2.2 Non-Hematological Cancer Treatment Growth Trends by Regions
2.2.1 Non-Hematological Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Non-Hematological Cancer Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Non-Hematological Cancer Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Non-Hematological Cancer Treatment Industry Dynamic
2.3.1 Non-Hematological Cancer Treatment Market Trends
2.3.2 Non-Hematological Cancer Treatment Market Drivers
2.3.3 Non-Hematological Cancer Treatment Market Challenges
2.3.4 Non-Hematological Cancer Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Non-Hematological Cancer Treatment Players by Revenue
3.1.1 Global Top Non-Hematological Cancer Treatment Players by Revenue (2016-2021)
3.1.2 Global Non-Hematological Cancer Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Non-Hematological Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Non-Hematological Cancer Treatment Revenue
3.4 Global Non-Hematological Cancer Treatment Market Concentration Ratio
3.4.1 Global Non-Hematological Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Hematological Cancer Treatment Revenue in 2020
3.5 Non-Hematological Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Non-Hematological Cancer Treatment Product Solution and Service
3.7 Date of Enter into Non-Hematological Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Non-Hematological Cancer Treatment Breakdown Data by Type
4.1 Global Non-Hematological Cancer Treatment Historic Market Size by Type (2016-2021)
4.2 Global Non-Hematological Cancer Treatment Forecasted Market Size by Type (2022-2027)

5 Non-Hematological Cancer Treatment Breakdown Data by Application
5.1 Global Non-Hematological Cancer Treatment Historic Market Size by Application (2016-2021)
5.2 Global Non-Hematological Cancer Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Non-Hematological Cancer Treatment Market Size (2016-2027)
6.2 North America Non-Hematological Cancer Treatment Market Size by Type
6.2.1 North America Non-Hematological Cancer Treatment Market Size by Type (2016-2021)
6.2.2 North America Non-Hematological Cancer Treatment Market Size by Type (2022-2027)
6.2.3 North America Non-Hematological Cancer Treatment Market Size by Type (2016-2027)
6.3 North America Non-Hematological Cancer Treatment Market Size by Application
6.3.1 North America Non-Hematological Cancer Treatment Market Size by Application (2016-2021)
6.3.2 North America Non-Hematological Cancer Treatment Market Size by Application (2022-2027)
6.3.3 North America Non-Hematological Cancer Treatment Market Size by Application (2016-2027)
6.4 North America Non-Hematological Cancer Treatment Market Size by Country
6.4.1 North America Non-Hematological Cancer Treatment Market Size by Country (2016-2021)
6.4.2 North America Non-Hematological Cancer Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Non-Hematological Cancer Treatment Market Size (2016-2027)
7.2 Europe Non-Hematological Cancer Treatment Market Size by Type
7.2.1 Europe Non-Hematological Cancer Treatment Market Size by Type (2016-2021)
7.2.2 Europe Non-Hematological Cancer Treatment Market Size by Type (2022-2027)
7.2.3 Europe Non-Hematological Cancer Treatment Market Size by Type (2016-2027)
7.3 Europe Non-Hematological Cancer Treatment Market Size by Application
7.3.1 Europe Non-Hematological Cancer Treatment Market Size by Application (2016-2021)
7.3.2 Europe Non-Hematological Cancer Treatment Market Size by Application (2022-2027)
7.3.3 Europe Non-Hematological Cancer Treatment Market Size by Application (2016-2027)
7.4 Europe Non-Hematological Cancer Treatment Market Size by Country
7.4.1 Europe Non-Hematological Cancer Treatment Market Size by Country (2016-2021)
7.4.2 Europe Non-Hematological Cancer Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Non-Hematological Cancer Treatment Market Size (2016-2027)
8.2 Asia-Pacific Non-Hematological Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Non-Hematological Cancer Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Non-Hematological Cancer Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Non-Hematological Cancer Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Non-Hematological Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Non-Hematological Cancer Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Non-Hematological Cancer Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Non-Hematological Cancer Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Non-Hematological Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Non-Hematological Cancer Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Non-Hematological Cancer Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Non-Hematological Cancer Treatment Market Size (2016-2027)
9.2 Latin America Non-Hematological Cancer Treatment Market Size by Type
9.2.1 Latin America Non-Hematological Cancer Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Non-Hematological Cancer Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Non-Hematological Cancer Treatment Market Size by Type (2016-2027)
9.3 Latin America Non-Hematological Cancer Treatment Market Size by Application
9.3.1 Latin America Non-Hematological Cancer Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Non-Hematological Cancer Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Non-Hematological Cancer Treatment Market Size by Application (2016-2027)
9.4 Latin America Non-Hematological Cancer Treatment Market Size by Country
9.4.1 Latin America Non-Hematological Cancer Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Non-Hematological Cancer Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Non-Hematological Cancer Treatment Market Size (2016-2027)
10.2 Middle East & Africa Non-Hematological Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Non-Hematological Cancer Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Non-Hematological Cancer Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Non-Hematological Cancer Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Non-Hematological Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Non-Hematological Cancer Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Non-Hematological Cancer Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Non-Hematological Cancer Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Non-Hematological Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Non-Hematological Cancer Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Non-Hematological Cancer Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Non-Hematological Cancer Treatment Introduction
11.1.4 Novartis Revenue in Non-Hematological Cancer Treatment Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Non-Hematological Cancer Treatment Introduction
11.2.4 Pfizer Revenue in Non-Hematological Cancer Treatment Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Non-Hematological Cancer Treatment Introduction
11.3.4 Bristol-Myers Squibb Revenue in Non-Hematological Cancer Treatment Business (2016-2021)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Non-Hematological Cancer Treatment Introduction
11.4.4 Johnson & Johnson Revenue in Non-Hematological Cancer Treatment Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Non-Hematological Cancer Treatment Introduction
11.5.4 Roche Revenue in Non-Hematological Cancer Treatment Business (2016-2021)
11.5.5 Roche Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Non-Hematological Cancer Treatment Introduction
11.6.4 Amgen Revenue in Non-Hematological Cancer Treatment Business (2016-2021)
11.6.5 Amgen Recent Development
11.7 Astellas Pharma
11.7.1 Astellas Pharma Company Details
11.7.2 Astellas Pharma Business Overview
11.7.3 Astellas Pharma Non-Hematological Cancer Treatment Introduction
11.7.4 Astellas Pharma Revenue in Non-Hematological Cancer Treatment Business (2016-2021)
11.7.5 Astellas Pharma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Non-Hematological Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Surgery
Table 4. Key Players of Radiation Therapy
Table 5. Key Players of Others
Table 6. Global Non-Hematological Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Non-Hematological Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Non-Hematological Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Non-Hematological Cancer Treatment Market Share by Regions (2016-2021)
Table 10. Global Non-Hematological Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Non-Hematological Cancer Treatment Market Share by Regions (2022-2027)
Table 12. Non-Hematological Cancer Treatment Market Trends
Table 13. Non-Hematological Cancer Treatment Market Drivers
Table 14. Non-Hematological Cancer Treatment Market Challenges
Table 15. Non-Hematological Cancer Treatment Market Restraints
Table 16. Global Non-Hematological Cancer Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Non-Hematological Cancer Treatment Market Share by Players (2016-2021)
Table 18. Global Top Non-Hematological Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Hematological Cancer Treatment as of 2020)
Table 19. Ranking of Global Top Non-Hematological Cancer Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Non-Hematological Cancer Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Non-Hematological Cancer Treatment Product Solution and Service
Table 23. Date of Enter into Non-Hematological Cancer Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Non-Hematological Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Non-Hematological Cancer Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Non-Hematological Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Non-Hematological Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Non-Hematological Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Non-Hematological Cancer Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Non-Hematological Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Non-Hematological Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Non-Hematological Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Non-Hematological Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Non-Hematological Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Non-Hematological Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Non-Hematological Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Non-Hematological Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Non-Hematological Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Non-Hematological Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Non-Hematological Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Non-Hematological Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Non-Hematological Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Non-Hematological Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Non-Hematological Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Non-Hematological Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Non-Hematological Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Non-Hematological Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Non-Hematological Cancer Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Non-Hematological Cancer Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Non-Hematological Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Non-Hematological Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Non-Hematological Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Non-Hematological Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Non-Hematological Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Non-Hematological Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Non-Hematological Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Non-Hematological Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Non-Hematological Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Non-Hematological Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Non-Hematological Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Non-Hematological Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Novartis Company Details
Table 64. Novartis Business Overview
Table 65. Novartis Non-Hematological Cancer Treatment Product
Table 66. Novartis Revenue in Non-Hematological Cancer Treatment Business (2016-2021) & (US$ Million)
Table 67. Novartis Recent Development
Table 68. Pfizer Company Details
Table 69. Pfizer Business Overview
Table 70. Pfizer Non-Hematological Cancer Treatment Product
Table 71. Pfizer Revenue in Non-Hematological Cancer Treatment Business (2016-2021) & (US$ Million)
Table 72. Pfizer Recent Development
Table 73. Bristol-Myers Squibb Company Details
Table 74. Bristol-Myers Squibb Business Overview
Table 75. Bristol-Myers Squibb Non-Hematological Cancer Treatment Product
Table 76. Bristol-Myers Squibb Revenue in Non-Hematological Cancer Treatment Business (2016-2021) & (US$ Million)
Table 77. Bristol-Myers Squibb Recent Development
Table 78. Johnson & Johnson Company Details
Table 79. Johnson & Johnson Business Overview
Table 80. Johnson & Johnson Non-Hematological Cancer Treatment Product
Table 81. Johnson & Johnson Revenue in Non-Hematological Cancer Treatment Business (2016-2021) & (US$ Million)
Table 82. Johnson & Johnson Recent Development
Table 83. Roche Company Details
Table 84. Roche Business Overview
Table 85. Roche Non-Hematological Cancer Treatment Product
Table 86. Roche Revenue in Non-Hematological Cancer Treatment Business (2016-2021) & (US$ Million)
Table 87. Roche Recent Development
Table 88. Amgen Company Details
Table 89. Amgen Business Overview
Table 90. Amgen Non-Hematological Cancer Treatment Product
Table 91. Amgen Revenue in Non-Hematological Cancer Treatment Business (2016-2021) & (US$ Million)
Table 92. Amgen Recent Development
Table 93. Astellas Pharma Company Details
Table 94. Astellas Pharma Business Overview
Table 95. Astellas Pharma Non-Hematological Cancer Treatment Product
Table 96. Astellas Pharma Revenue in Non-Hematological Cancer Treatment Business (2016-2021) & (US$ Million)
Table 97. Astellas Pharma Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-Hematological Cancer Treatment Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Surgery Features
Figure 4. Radiation Therapy Features
Figure 5. Others Features
Figure 6. Global Non-Hematological Cancer Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Oncology Treatment Centre Case Studies
Figure 9. Ambulatory Surgery Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Non-Hematological Cancer Treatment Report Years Considered
Figure 12. Global Non-Hematological Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Non-Hematological Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Non-Hematological Cancer Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Non-Hematological Cancer Treatment Market Share by Regions (2022-2027)
Figure 16. Global Non-Hematological Cancer Treatment Market Share by Players in 2020
Figure 17. Global Top Non-Hematological Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Hematological Cancer Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Non-Hematological Cancer Treatment Revenue in 2020
Figure 19. Global Non-Hematological Cancer Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Non-Hematological Cancer Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Non-Hematological Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Non-Hematological Cancer Treatment Market Share by Type (2016-2027)
Figure 23. North America Non-Hematological Cancer Treatment Market Share by Application (2016-2027)
Figure 24. North America Non-Hematological Cancer Treatment Market Share by Country (2016-2027)
Figure 25. United States Non-Hematological Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Non-Hematological Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Non-Hematological Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Non-Hematological Cancer Treatment Market Share by Type (2016-2027)
Figure 29. Europe Non-Hematological Cancer Treatment Market Share by Application (2016-2027)
Figure 30. Europe Non-Hematological Cancer Treatment Market Share by Country (2016-2027)
Figure 31. Germany Non-Hematological Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Non-Hematological Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Non-Hematological Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Non-Hematological Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Non-Hematological Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Non-Hematological Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Non-Hematological Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Non-Hematological Cancer Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Non-Hematological Cancer Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Non-Hematological Cancer Treatment Market Share by Region (2016-2027)
Figure 41. China Non-Hematological Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Non-Hematological Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Non-Hematological Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Non-Hematological Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Non-Hematological Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Non-Hematological Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Non-Hematological Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Non-Hematological Cancer Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Non-Hematological Cancer Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Non-Hematological Cancer Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Non-Hematological Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Non-Hematological Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Non-Hematological Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Non-Hematological Cancer Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Non-Hematological Cancer Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Non-Hematological Cancer Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Non-Hematological Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Non-Hematological Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Non-Hematological Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Novartis Revenue Growth Rate in Non-Hematological Cancer Treatment Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Non-Hematological Cancer Treatment Business (2016-2021)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Non-Hematological Cancer Treatment Business (2016-2021)
Figure 63. Johnson & Johnson Revenue Growth Rate in Non-Hematological Cancer Treatment Business (2016-2021)
Figure 64. Roche Revenue Growth Rate in Non-Hematological Cancer Treatment Business (2016-2021)
Figure 65. Amgen Revenue Growth Rate in Non-Hematological Cancer Treatment Business (2016-2021)
Figure 66. Astellas Pharma Revenue Growth Rate in Non-Hematological Cancer Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---